According to Prof. Michael Farzan, the SCRIPPS Research Institute virologist who discovered the angiotensin-converting enzyme 2 (ACE2) receptor binding site of SARS-CoV-2 [8], the level of complexity is significantly lower due to its low resistance to our immune system, suggesting that a single vaccine would work to prevent COVID-19 [9]. Here, ACE2 is linked to COVID-19.